• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.

作者信息

Liu Anding, Wang Wenjie, Zhao Xuecheng, Zhou Xiaoxi, Yang Dongliang, Lu Mengji, Lv Yongman

机构信息

Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

Clin Microbiol Infect. 2020 Dec;26(12):1703-1705. doi: 10.1016/j.cmi.2020.07.009. Epub 2020 Jul 9.

DOI:10.1016/j.cmi.2020.07.009
PMID:32653658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7346807/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e56c/7346807/1bc18626c9b9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e56c/7346807/1bc18626c9b9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e56c/7346807/1bc18626c9b9/gr1_lrg.jpg

相似文献

1
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.一名新冠康复患者体内新冠病毒抗体消失。
Clin Microbiol Infect. 2020 Dec;26(12):1703-1705. doi: 10.1016/j.cmi.2020.07.009. Epub 2020 Jul 9.
2
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征（MIS-C）中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
3
A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.一种基于多重珠粒的流动分析系统的快速、多重双报告人 IgG 和 IgM SARS-CoV-2 中和测定法。
J Vis Exp. 2021 Apr 6(170). doi: 10.3791/62487.
4
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.利用具有 SARS-CoV-2 刺突蛋白的水疱性口炎病毒评估 SARS-CoV-2 中和抗体。
Virol J. 2021 Jan 12;18(1):16. doi: 10.1186/s12985-021-01490-7.
5
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.在 COVID-19 和恢复期，针对 SARS-CoV-2 刺突和核衣壳蛋白快速产生持久的 B 细胞记忆。
Sci Immunol. 2020 Dec 22;5(54). doi: 10.1126/sciimmunol.abf8891.
6
Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays.新型冠状病毒2型免疫球蛋白G和免疫球蛋白M血清学检测在儿科临床中的特异性和敏感性评估
Clin Chem Lab Med. 2021 Jan 22;59(6):e235-e237. doi: 10.1515/cclm-2020-1822. Print 2021 May 26.
7
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.无症状 SARS-CoV-2 感染病例的血清学调查显示，抗体反应较弱且逐渐减弱。
Emerg Microbes Infect. 2021 Dec;10(1):905-912. doi: 10.1080/22221751.2021.1919032.
8
The complexities of SARS-CoV-2 serology.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学的复杂性。
Lancet Infect Dis. 2020 Dec;20(12):1350-1351. doi: 10.1016/S1473-3099(20)30699-X. Epub 2020 Sep 23.
9
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.新冠肺炎患者血清中数月来持续存在对 SARS-CoV-2 的中和活性。
Viruses. 2020 Nov 27;12(12):1357. doi: 10.3390/v12121357.
10
Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.单剂 SARS-CoV-2 mRNA 疫苗后的抗体反应。
N Engl J Med. 2021 May 20;384(20):1959-1961. doi: 10.1056/NEJMc2102051. Epub 2021 Mar 23.

引用本文的文献

1
Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.泰国有症状和无症状的新冠病毒感染者的抗体反应。
PLoS One. 2025 Feb 11;20(2):e0308850. doi: 10.1371/journal.pone.0308850. eCollection 2025.
2
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate.接受干扰素β和富马酸二甲酯治疗的复发缓解型多发性硬化症患者接种新冠病毒疫苗后的体液免疫和细胞免疫
Biomedicines. 2025 Jan 9;13(1):153. doi: 10.3390/biomedicines13010153.
3
Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 Infection.

本文引用的文献

1
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.高通量单细胞测序鉴定恢复期患者 B 细胞中的 SARS-CoV-2 强效中和抗体。
Cell. 2020 Jul 9;182(1):73-84.e16. doi: 10.1016/j.cell.2020.05.025. Epub 2020 May 18.
2
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.新型冠状病毒感染恢复期个体中 SARS-CoV-2 特异性体液和细胞免疫的检测。
Immunity. 2020 Jun 16;52(6):971-977.e3. doi: 10.1016/j.immuni.2020.04.023. Epub 2020 May 3.
3
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
新型冠状病毒感染后IgG抗体持久性及相关症状的九个月趋势
Healthcare (Basel). 2024 May 5;12(9):948. doi: 10.3390/healthcare12090948.
4
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19.COVID-19患者抗SARS-CoV-2抗体谱的比较纵向血清学研究
Microorganisms. 2023 Aug 2;11(8):1985. doi: 10.3390/microorganisms11081985.
5
Biomarkers of sequela in adult patients convalescing from COVID-19.COVID-19康复期成年患者后遗症的生物标志物
Adv Biomark Sci Technol. 2022;4:36-53. doi: 10.1016/j.abst.2022.10.001. Epub 2022 Nov 9.
6
Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19.COVID-19 住院患者体内病毒特异性抗体分泌细胞的持续产生、亲和力成熟和 B 细胞进化。
Viral Immunol. 2022 Apr;35(3):259-272. doi: 10.1089/vim.2021.0191. Epub 2022 Mar 14.
7
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies.抗 SARS-CoV-2 IgG 抗体的长期持久性。
Curr Microbiol. 2022 Feb 12;79(4):96. doi: 10.1007/s00284-022-02800-0.
8
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.接种 SARS-CoV-2 疫苗或感染一年后均可检测到强大的中和抗体水平。
Viruses. 2021 Oct 5;13(10):2003. doi: 10.3390/v13102003.
9
SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.COVID-19 恢复期个体中的 SARS-CoV-2 特异性免疫应答。
Signal Transduct Target Ther. 2021 Jul 7;6(1):256. doi: 10.1038/s41392-021-00686-1.
10
Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.评价 2 种商业抗 SARS-CoV-2 抗体检测试剂盒在伴有 COVID-19 的免疫功能正常和免疫功能低下住院患者中的应用。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115449. doi: 10.1016/j.diagmicrobio.2021.115449. Epub 2021 Jun 5.
新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
4
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.2015年韩国，中东呼吸综合征冠状病毒症状出现1年后的抗体反应
Emerg Infect Dis. 2017 Jul;23(7):1079-1084. doi: 10.3201/eid2307.170310. Epub 2017 Jul 15.
5
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.针对严重急性呼吸综合征冠状病毒的记忆性T细胞反应在感染后持续长达11年。
Vaccine. 2016 Apr 12;34(17):2008-14. doi: 10.1016/j.vaccine.2016.02.063. Epub 2016 Mar 5.
6
Disappearance of antibodies to SARS-associated coronavirus after recovery.康复后与严重急性呼吸综合征相关冠状病毒抗体的消失。
N Engl J Med. 2007 Sep 13;357(11):1162-3. doi: 10.1056/NEJMc070348.